Home Alzheimer’s Disease Adults with NSCLC and Impaired Performance Status Face Shorter Survival after ICI...

Adults with NSCLC and Impaired Performance Status Face Shorter Survival after ICI Treatment

Adults with advanced non-small cell lung cancer (NSCLC) and impaired performance status (PS) experience significantly shorter survival after treatment with immune checkpoint inhibitors (ICIs) and receive ICIs more often than those with better performance status, according to a study published in Cancer.

The researchers indicated that these findings align with prior retrospective evidence suggesting the need for the incorporation of adults with performance status ≥2 into randomized clinical trials.

“This collective evidence helps clarify that survival outcomes from pivotal phase III clinical trials of ICIs may not be generalizable to adults with impaired PS,” the authors wrote. “Therefore, caution should be used in counseling functionally impaired adults who are facing decisions about whether to pursue ICI treatment for advanced NSCLC.”

In this retrospective, single-site…

Continue Reading to the Source

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

How has COVID-19 affected the global cancer community? – IBTA

Save the date: Coalition Connection: COVID-19 on 4 February 06:30am PST/ 09:30am EST/ 02:30pm GMT/ 03:30pm CET On 4th February 2021, the Global Cancer Coalition Network...

Parasite found in undercooked meat linked with risk of rare brain cancer

submitted by /u/Meat_Mithkabob Continue Reading to the Source

Living up to expectations : braincancer

Hey everyone!I wrote a little something about some of the comments you often hear from others and how sometimes you feel like you need...

Recent Comments